Furthermore, high plasma fibrinogen levels were linked to a poor response to trastuzumab treatment in HER2 positive BC patients [40] and circulating levels of factor VIII (FVIII) were found to be significantly related to axillary lymph node involvement, the number of metastatic nodes, and HER2 status [78]. This evidence concerns the gene ERBB2 and breast cancer.